Claudia Filozof

1.9k total citations
28 papers, 1.5k citations indexed

About

Claudia Filozof is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Claudia Filozof has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Claudia Filozof's work include Liver Disease Diagnosis and Treatment (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Claudia Filozof is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Pancreatitis Pathology and Treatment (4 papers). Claudia Filozof collaborates with scholars based in United States, Spain and Switzerland. Claudia Filozof's co-authors include A Fernández‐Cruz, Jean–François Gautier, Claudio González, C. A. da S. Mazza, Barry J. Goldstein, Arun J. Sanyal, Manal F. Abdelmalek, Carlos Brailovsky, Éric Ravussin and M. Perman and has published in prestigious journals such as Diabetes, Journal of the American Society of Nephrology and Journal of Hepatology.

In The Last Decade

Claudia Filozof

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Filozof United States 17 453 430 395 302 219 28 1.5k
Hee‐Taik Kang South Korea 24 455 1.0× 478 1.1× 436 1.1× 355 1.2× 233 1.1× 114 1.8k
C. Druet France 17 314 0.7× 639 1.5× 474 1.2× 225 0.7× 157 0.7× 27 1.4k
Ching-Yun Wang United States 22 699 1.5× 462 1.1× 199 0.5× 238 0.8× 311 1.4× 30 2.2k
T. T. Valle Finland 20 701 1.5× 362 0.8× 573 1.5× 337 1.1× 207 0.9× 25 1.5k
Rimei Nishimura Japan 23 216 0.5× 356 0.8× 515 1.3× 230 0.8× 267 1.2× 70 1.4k
Christine Massien France 13 459 1.0× 434 1.0× 563 1.4× 372 1.2× 231 1.1× 23 1.6k
Toba Kazemi Iran 22 288 0.6× 271 0.6× 254 0.6× 236 0.8× 260 1.2× 197 1.8k
Lars Ängquist Denmark 25 659 1.5× 1.0k 2.4× 303 0.8× 263 0.9× 265 1.2× 98 2.2k
Themistoklis Tzotzas Greece 24 325 0.7× 654 1.5× 355 0.9× 139 0.5× 93 0.4× 44 1.4k
Patricia J. Coon United States 21 590 1.3× 282 0.7× 422 1.1× 245 0.8× 188 0.9× 30 1.6k

Countries citing papers authored by Claudia Filozof

Since Specialization
Citations

This map shows the geographic impact of Claudia Filozof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Filozof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Filozof more than expected).

Fields of papers citing papers by Claudia Filozof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Filozof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Filozof. The network helps show where Claudia Filozof may publish in the future.

Co-authorship network of co-authors of Claudia Filozof

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Filozof. A scholar is included among the top collaborators of Claudia Filozof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Filozof. Claudia Filozof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Yayun, Jenghwa Chang, Dean Tai, et al.. (2025). Repeatability and Reproducibility of Artificial Imaging-based Digital Pathology for the Evaluation of Liver Fibrosis. Clinical Gastroenterology and Hepatology. 24(3). 713–722. 1 indexed citations
3.
Filozof, Claudia, Carolin Lackner, Manuel Romero‐Gómez, et al.. (2022). Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion. IUScholarWorks (Indiana University). 2022. 1–11. 5 indexed citations
4.
Ezaz, Ghideon, Hirsh D. Trivedi, Margery A. Connelly, et al.. (2020). Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD. Hepatology Communications. 4(5). 670–680. 29 indexed citations
5.
Glass, Oliver, Claudia Filozof, Mazen Noureddin, et al.. (2020). Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum. Journal of Hepatology. 73(3). 680–693. 71 indexed citations
6.
Filozof, Claudia, Stephen C. Jones, & Barry J. Goldstein. (2018). Liver Fibrosis as Assessed by the FIB-4 Index in Patients with Type 2 Diabetes (T2DM). Diabetes. 67(Supplement_1). 4 indexed citations
9.
Mathieu, Chantal, Claudia Filozof, & Anthony Barnett. (2010). Hypoglycaemia in Type 2 Diabetes – Clinical Consequences and Impact on Treatment. touchREVIEWS in Endocrinology. 6. 29–29. 1 indexed citations
11.
Filozof, Claudia, et al.. (2007). Relationship between plasma levels of soluble CD40L and insulin sensitivity and insulin secretion status in non-diabetic dyslipidemic patients. Diabetes Research and Clinical Practice. 79(1). 48–55. 8 indexed citations
12.
Gómez, Pablo, Luís M. Ruilope, Vivencio Barrios, et al.. (2006). Prevalence of Renal Insufficiency in Individuals with Hypertension and Obesity/Overweight. Journal of the American Society of Nephrology. 17(12_suppl_3). S194–S200. 19 indexed citations
13.
Redón, Josep, Francisco J. Morales‐Olivas, Rafael Marín, et al.. (2006). Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension. Journal of the American Society of Nephrology. 17(12_suppl_3). S236–S245. 23 indexed citations
14.
Marín, Rafael, Salvador Tranche, Josep Redón, et al.. (2006). Prevalence of Abnormal Urinary Albumin Excretion Rate in Hypertensive Patients with Impaired Fasting Glucose and Its Association with Cardiovascular Disease. Journal of the American Society of Nephrology. 17(12_suppl_3). S178–S188. 19 indexed citations
15.
Badı́a, Xavier, Hermenegildo de la Calle, Claudia Filozof, et al.. (2005). Tratamiento de los pacientes con diabetes mellitus tipo 2 en atención primaria en España. Medicina Clínica. 125(5). 166–172. 48 indexed citations
16.
Filozof, Claudia, et al.. (2005). Smoking cessation and weight gain.. Obesity and metabolism. 2(1). 44–44. 199 indexed citations
17.
Filozof, Claudia, et al.. (2004). Smoking cessation and weight gain. Obesity Reviews. 5(2). 95–103. 405 indexed citations
18.
Filozof, Claudia, et al.. (2001). Obesity prevalence and trends in Latin‐American countries. Obesity Reviews. 2(2). 99–106. 196 indexed citations
19.
Filozof, Claudia & Claudio González. (2000). Predictors of weight gain: the biological‐behavioural debate. Obesity Reviews. 1(1). 21–26. 25 indexed citations
20.
Filozof, Claudia, et al.. (2000). Low Plasma Leptin Concentration and Low Rates of Fat Oxidation in Weight‐Stable Post‐Obese Subjects. Obesity Research. 8(3). 205–210. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026